Current Rheumatology Reviews

Editorial [Hot topic: Utilization of Biology Therapy in Spondyloarthropathy (SpA) in Asia Countries (Guest Editor: Chung-Tei Chou)]
pp. 148-148(1)
Author: Chou, Chung-Tei

The Use of Biologics for Psoriasis in Asia-Pacific Region
pp. 149-152(4)
Authors: Tsai, Tsen-Fang; Yeh, Ting-Yu

Other Future Targeting Therapy Beyond TNF-α Inhibitor in Patients with Spondyloarthropathy
pp. 153-157(5)
Authors: Tsai, Wen-Chan; Ou, Tsang-Teng; Wu, Chen-Ching

Anti Tumor Necrosis Factor Alpha (TNFα) Therapy in Ankylosing Spondylitis - Asian Perspective
pp. 158-164(7)
Authors: Lee, Tsz Y.; Huang, Feng

Which Biomarker is Useful to Evaluate as a Treatment Outcome in Spondyloarthritis?
pp. 165-168(4)
Authors: Lee, Sang-Hoon; Kim, Tae H.

Early Diagnosis of AS or Other SpA - From Clinical and Radiologic Viewpoint
pp. 169-173(5)
Authors: Kumar, Ashok; Das, Chandan J.

Anti-Tumor Necrosis Factor-α Therapy in Undifferentiated Spondyloarthritis (USpA)
pp. 174-176(3)
Authors: Liao, Hsien-Tzung; Chen, Chun-Hsiung; Chen, Wei-Sheng; Lee, Hui-Ting; Tsai, Chang-Youh; Chou, Chung-Tei

Demographic Characteristic of Ankylosing Spondylitis in Chinese
pp. 177-181(5)
Authors: Chen, Chun-Hsiung; Chen, Hung-An; Liao, Hsien-Tzung; Liu, Chin-Hsiu; Liang, Toong-Hua; Tsai, Chang-Youh; Chou, Chung-Tei

The Characteristic of Histopathology in Spondyloarthropathy
pp. 182-185(4)
Authors: Chen, Wei-Sheng; Tsai, Chang-Youh; Chou, Chung-Tei